FDA Halts MM Trial, Deaths Seen in Venclexta Arm

The FDA halted a clinical trial of Venclexta for MM because of an increased risk for death; does not affect ...

MARCH 22, 2019

FDA Approves Crysvita for Rare Rickets

The FDA approved Crysvita, the first drug indicated for adults and children aged 1 year and older with X-linked ...

APRIL 18, 2018

Women, Minorities May Be Undertreated for Stroke

Although the clot-busting treatment for stroke called tPA improves recovery, some people who should get it, aren't. ...

SEPTEMBER 15, 2016

Pay Now or Pay More Later: Treating HCV

The cost of curing HCV in the long term is much cheaper than the ongoing expense of older therapies or delayed ...

MAY 10, 2016

FDA Approves Inflectra, Biosimilar to Remicade

Inflectra is the second U.S. biosimilar approved and the first monoclonal antibody.

APRIL 6, 2016

FDA Approves Taltz To Treat Psoriasis

Psoriasis affects about 7.5 million Americans, 20% of whom have moderate to severe plaque psoriasis.

MARCH 23, 2016

The FDA Approves Zepatier To Treat HCV 

Zepatier achieves SVR12 in a broad range of HCV patients, including those with compensated cirrhosis, renal ...

JANUARY 29, 2016